Enveric Biosciences Enters Material Definitive Agreement
Ticker: ENVB · Form: 8-K · Filed: Jul 15, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Jul 15, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, company-name-change
TL;DR
Enveric Bio just signed a big deal, filing shows.
AI Summary
Enveric Biosciences, Inc. announced on July 10, 2024, that it entered into a material definitive agreement. The company, previously known as Ameri Holdings, Inc. and Spatializer Audio Laboratories Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates a significant new contract or partnership for Enveric Biosciences, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry inherent risks related to the terms, execution, and potential impact on the company's strategic direction.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- AMERI Holdings, Inc. (company) — Former Company Name
- SPATIALIZER AUDIO LABORATORIES INC (company) — Former Company Name
- July 10, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Enveric Biosciences?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on July 10, 2024.
When was Enveric Biosciences incorporated?
Enveric Biosciences, Inc. was incorporated in Delaware.
What is Enveric Biosciences' Standard Industrial Classification code?
Enveric Biosciences, Inc. has a Standard Industrial Classification code of 2834, which corresponds to Pharmaceutical Preparations.
What were Enveric Biosciences' former company names?
Enveric Biosciences, Inc. was formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC.
What is the principal executive office address for Enveric Biosciences?
The principal executive offices of Enveric Biosciences, Inc. are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
Filing Stats: 667 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2024-07-15 08:00:39
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-027235.txt ( ) — 237KB
- envb-20240710.xsd (EX-101.SCH) — 3KB
- envb-20240710_lab.xml (EX-101.LAB) — 33KB
- envb-20240710_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated July 15, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 15, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer